NAL-NL2 is the second generation of prescription procedures from The National Acoustic Laboratories (NAL) for fitting wide dynamic range compression (WDRC) instruments. Like its predecessor NALNL1 (Dillon, 1999), NAL-NL2 aims at making speech intelligible and overall loudness comfortable. This aim is mainly driven by a belief that these factors are most important for hearing aid users, but is also driven by the fact that less information is available about how to adjust gain to optimise other parameters that affect prescription such as localisation, tonal quality, detection of environmental sounds, and naturalness. In both formulas, the objective is achieved by combining a speech intelligibility model and a loudness model in an adaptive computer- controlled optimisation process. Adjustments have further been made to the theoretical component of NAL-NL2 that are directed by empirical data collected during the past decade with NAL-NL1. In this paper, the data underlying NAL-NL2 and the derivation procedure are presented, and the main differences from NAL-NL1 are outlined
Abstract. The mixed mode cochlear amplifier (MMCA) model is derived from the physiology of the cochlea. It is comprised of three main elements of the peripheral hearing system: the cochlear mechanics, hair cell motility, and neurophysiology. This model expresses both active compression wave and active traveling wave modes of operation. The inclusion of a neural loop with a time delay, and a new paradigm for the mechanical response of the outer hair cells, are believed to be unique features of the MMCA. These elements combine to form an active feedback loop to constitute the cochlear amplifier, whose input is a passive traveling wave vibration. The result is a cycle-by-cycle amplifier with nonlinear response. This system can assume an infinite number of different operating states. The stable state and the first few amplitude-limited unstable (Hopf-bifurcated) states are significant in describing the operation of the peripheral hearing system. A hierarchy of models can be constructed from this concept, depending on the amount of detail included. The simplest model of the MMCA is a nonlinear delay line resonator. It was found that even this simple MMCA version can explain a large number of hearing phenomena, at least qualitatively. This paper concentrates on explaining the fractional octave shift from the living to postmortem response in terms of the new model. Other mechanical, hair cell and neurological phenomena can also be accounted for by the MMCA, including two-tone suppression behavior, distortion product responses, otoacoustic emissions and neural spontaneous rates.
Abstract. The mixed mode cochlear amplifier (MMCA) model was presented at the last Mechanics of Hearing workshop [4]. The MMCA consists principally of a nonlinear feedback loop formed when an efferent-controlled outer hair cell (OHC) is combined with the cochlear mechanics and the rest of the relevant neurobiology. Essential elements of this model are efferent control of the OHC motility and a delay in the feedback to the OHC. The input to the MMCA is the passive travelling wave. In the MMCA amplification is localized where both the neural and tuned mechanical systems meet in the Organ of Corti (OoC). The simplest model based on this idea is a nonlinear delay line resonator (DLR), which is mathematically described by a nonlinear delay-differential equation (DDE). This model predicts possible Hopf bifurcations and exhibits its most interesting behaviour when operating near a bifurcation. This contribution presents some simulation results using the DLR model. These show that various observed hearing phenomena can be accounted for by this model, at least qualitatively, including compression effects, two-tone suppression and some forms of otoacoustic emissions (OAEs).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.